ReviewProceedings of the Japan Academy. Series B, Physical and biological sciences2026
Glyoxalase activities of Parkinson's disease relevant protein DJ-1/PARK7: Past discoveries and future perspectives.
Review in Proceedings of the Japan Academy. Series B, Physical and biological sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Loss-of-function mutations in the evolutionarily conserved protein DJ-1/PARK7 cause autosomal recessive early-onset Parkinson's disease. Despite being identified more than 20 years ago, the authentic molecular function of DJ-1 remains controversial as diverse biochemical activities attributed to DJ-1 often lack a unified mechanistic explanation. In this review, we outline the hydrolase activities of DJ-1 (i.e., deglycase, protease, and esterase activities) before focusing on its glyoxalase activity, which catalyzes the glutathione-independent detoxification of reactive α-oxoaldehydes such as methylglyoxal. We summarize the historical identification of glyoxalase III activity, the discovery of bacterial and fungal DJ-1 homologs as methylglyoxalases, and the extension of this concept to human DJ-1. Structural and biochemical studies have clarified the molecular mechanism by which DJ-1 hydrolyzes glyoxal and methylglyoxal. In this mechanism, the conserved active-site cysteine residue (Cys106), together with neighboring residues, such as Glu18 and the Gly74-Gly75 oxyanion hole, cooperatively contribute to methylglyoxal degradation. These insights provide a coherent molecular framework that reconciles enzymatic activity with the structural features and evolutionary conservation of the DJ-1 family. Together, they provide a foundation for understanding the biological basis of DJ-1-mediated α-oxoaldehyde detoxification. Lastly, the limitations and unresolved questions of the DJ-1 glyoxalase hypothesis are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.